More than 25,000 bottles of a blood pressure medication have been recalled after failing safety tests. Patients are being urged to contact their pharmacist to check their medication.
Why the recall was issued
Inventia Healthcare Limited issued the voluntary recall in the US via the Food and Drug Administration (FDA) on September 3. It covered 13,567 bottles of 25mg chlorthalidone tablets.
In June, the same company issued a recall for 11,460 bottles of the same drug, taking the total to 25,027 bottles affected. Both recalls were issued for the same reason, reports Healthline.
What the safety test found
The FDA enforcement notice said the pills failed dissolution specification, which means they are not releasing the medication into the body as intended.
Chlorthalidone is a 'water tablet', aka a diuretic, often used to treat high blood pressure, fluid retention, heart failure, and diabetes insipidus. Usually, patients are told to take the pill at breakfast to avoid disrupting their sleep.
Which batches are affected
Three batches of the drug, which all expire in April 2027, are subject to the recall. The pills are light yellow in colour and have '103' stamped on one side, but are blank on the other.
Exact details of the batches have been released so patients can call the pharmacy which dispensed their last prescription to check the batch numbers and see if they are subject to the recall.
The batches affected are: recall initiated on September 3, 2026; 13,567 bottles affected. Batch: RISA24002, 100-tablet bottles, NDC 64980-599-01. June 2026 recall (recall number D-0610-2026) initiated on June 5, 2026; 11,460 bottles affected. Batch RISA24001, 100-tablet bottles, NDC 64980-599-01. Batch RISB24002, 1,000-tablet bottles, NDC 64980-599-10.
